Pharmacoeconomics and policy decisions: The Australian Health Care System

David Henry*, Ruth Lopert

*Corresponding author for this work

Research output: Contribution to journalReview articleResearchpeer-review

6 Citations (Scopus)

Abstract

This paper provides an overview of the use of pharmacoeconomic analysis in the process that governs drug reimbursement decisions in Australia. It discusses the methods by which drugs are evaluated, both clinically and economically, and the means by which these 2 facets are amalgamated; the types of pharmacoeconomic data submitted in support of requests for reimbursement; the methods and standards used to assess these data; some of the more commonly encountered flaws in the data submitted; and how the different types of data influence reimbursement decisions.

Original languageEnglish
Pages (from-to)909-915
Number of pages7
JournalClinical Therapeutics
Volume21
Issue number5
DOIs
Publication statusPublished - 1999
Externally publishedYes

    Fingerprint

Cite this